Sophia Koo, MD
Enriched profileAssistant Professor of Medicine at Harvard Medical School · Brigham and Women's Hospital
Sophia Koo is Assistant Professor of Medicine at Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 127 publications with 5,059 citations (h-index 35); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 22 Oct 2026
Sophia Koo, M.D., is Assistant Professor of Medicine at Harvard Medical School at Brigham and Women's Hospital. The public record shows 127 publications with 5,059 citations (h-index 35), centered on Antifungal resistance and susceptibility, Fungal Infections and Studies, Neutropenia and Cancer Infections. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies, 8 NIH-funded awards (2012–2026).
- Most recent indexed publication: 2026 · Transplant infectious disease
- Top research focus: Antifungal resistance and susceptibility
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Research focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 58.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 22 Oct 2026
1 company reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20252 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20243 payments$10,175openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.2%Statin54.2%Pravastatin Sodium100%Part D<11 patientsMetabolism & gastrointestinal
45.8%Proton pump inhibitor45.8%Esomeprazole Magnesium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
8 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States
Brigham and Women'S Hospital
FY2026$1,184,627U01TR004072 - Rapid, Breath Volatile Metabolite-Based Diagnosis, Species Identification, and Antibiotic Resistance Profiling in Bacterial Pneumonia
Brigham and Women'S Hospital
FY2026$751,760R01AI175040 - A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States
Brigham and Women'S Hospital
FY2025$1,190,094U01TR004072
Congress activity
Updated 22 Oct 2026
2 congress contributions (2004–2024) across ASCO, ASH per OpenAlex. The most recent:
- BK Virus Reactivation and Disease after Allogeneic Hematopoietic-Cell Transplantation: A Natural History Study
ASH Annual Meeting
ASH2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Immunocompromised Host Infectious Diseases: A Recommended Educational Content Outline for Advanced Practice Providers.
Transplant infectious disease
Article2026 - A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients.
American journal of transplantation
Article2022
Most-cited works
by citation count (OpenAlex)- 01Marital Status and Survival in Patients With CancerArticle1,032 citations2013
- 02Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized PatientsArticle943 citations2005
- 03Diagnostic Performance of the (1→3)‐β‐ d ‐Glucan Assay for Invasive Fungal DiseaseArticle220 citations2009
- 04
- 05
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- SM in Epidemiology
Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Awards & honors
honors on the public record- Top Doctor Award2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
Secondary affiliations
appointments beyond the home institution- Dana-Farber Cancer Institute
Staff Physician
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital